Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Voriconazole-induced pseudoporphyria.

J P Tolland1, P P McKeown, J R Corbett

  • 1Department of Dermatology, Belfast City Hospital Trust, Royal Hospitals Trust Belfast, Belfast. julia.tolland@gmail.com

Photodermatology, Photoimmunology & Photomedicine
|January 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Educational interventions in neurology: a comprehensive systematic review--reply to letter.

European journal of neurology·2013
Same author

Exercise training improves activity in adolescents with congenital heart disease.

Heart (British Cardiac Society)·2013
Same author

Educational interventions in neurology: a comprehensive systematic review.

European journal of neurology·2013
Same author

Spectrum of physiological and pathological cardiac and pericardial uptake of FDG in oncology PET-CT.

Clinical radiology·2012
Same author

Nutritional intake and oxidative stress in chronic heart failure.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2010
Same author

Lipomatous metaplasia within an old anterior myocardial infarction.

QJM : monthly journal of the Association of Physicians·2010
Same journal

Combination Therapy With Microneedle Radiofrequency Followed by Low-Fluence 1064-Nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Melasma: A Case Series.

Photodermatology, photoimmunology & photomedicine·2026
Same journal

Primary Cutaneous CD4+ Small/Medium Sized T-Cell Lymphoproliferative Disorder Presenting in the Setting of Chronic Actinic Dermatitis.

Photodermatology, photoimmunology & photomedicine·2026
Same journal

Enhancing Photoprotection: Assessing Visible Light Photoprotection in Tinted Inorganic Sunscreens.

Photodermatology, photoimmunology & photomedicine·2026
Same journal

Combination of Oral Gliadin-Protected Superoxide Dismutase With Targeted Phototherapy in Vitiligo: A Prospective, Comparative, Randomized, Single-Blinded Study.

Photodermatology, photoimmunology & photomedicine·2026
Same journal

Exploring the Impact of Phototherapy on Cardiovascular Events and Survival in Cutaneous T-Cell Lymphoma.

Photodermatology, photoimmunology & photomedicine·2026
Same journal

Erlotinib and Leflunomide Disrupt 6-Formylindolo[3,2-b]Carbazole Metabolism and Sensitize Keratinocytes to UVA Radiation-Induced Apoptosis.

Photodermatology, photoimmunology & photomedicine·2026
See all related articles

Pseudoporphyria, a skin condition causing sun sensitivity, can be triggered by medications. This report details a rare case of drug-induced pseudoporphyria linked to voriconazole, an antifungal drug.

Area of Science:

  • Dermatology
  • Pharmacology
  • Infectious Diseases

Background:

  • Pseudoporphyria is a skin condition characterized by blistering and photosensitivity.
  • It is most commonly associated with the ingestion of various medications.
  • Voriconazole is a widely used triazole antifungal agent for treating fungal infections.

Observation:

  • This report describes the third documented case of pseudoporphyria linked to voriconazole use.
  • The patient was undergoing treatment for a disseminated candidal infection.

Findings:

  • The patient developed pseudoporphyria as an adverse effect of voriconazole therapy.
  • This highlights a rare but significant side effect of this antifungal medication.

Implications:

Related Experiment Videos

  • Clinicians should be aware of the potential for voriconazole to induce pseudoporphyria.
  • Early recognition and management are crucial for patients experiencing photosensitivity during voriconazole treatment.
  • Further investigation into the mechanisms underlying voriconazole-induced pseudoporphyria may be warranted.